UBIO logo

UBIO ETF

Profile

Name:

ProShares UltraPro Nasdaq Biotechnology

Assets under management:

$0

Expense ratio:

0.00%

Inception date:

22 June 2015

Last ex-dividend date:

N/A

Next ex-dividend date:

N/A

Description:

The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index® (the "index"). The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Name
Weight
Net Other Assets (Liabilities)
100.00 %

Holding types

Countries

Sectors

No data

Analyst ratings

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

FAQ

  • What is UBIO ETF?
  • Does UBIO pay dividends?
  • What stocks are in UBIO ETF?
  • What is the current assets under management for UBIO?
  • What is UBIO average volume?
  • What is UBIO expense ratio?
  • What is UBIO inception date?

What is UBIO ETF?

The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index® (the "index"). The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Does UBIO pay dividends?

No, the ProShares UltraPro Nasdaq Biotechnology doesn't pay dividends

What stocks are in UBIO ETF?

As of today, ProShares UltraPro Nasdaq Biotechnology inlcudes 1 holdings with the most weighted are Net Other Assets (Liabilities) (100%)

What is the current assets under management for UBIO?

Assets under management of ProShares UltraPro Nasdaq Biotechnology is $0

What is UBIO average volume?

Average volume of ProShares UltraPro Nasdaq Biotechnology is $0

What is UBIO expense ratio?

Expense ratio of ProShares UltraPro Nasdaq Biotechnology is 0.00%

What is UBIO inception date?

Inception date of ProShares UltraPro Nasdaq Biotechnology is 22 June 2015